Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
for Lung Non-Small Cell Carcinoma
Drug: Atezolizumab
10 locations incl. Coeur d'Alene
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT07388524·Phase 3·Recruiting